UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
life sciences & biomedicine (171) 171
science & technology (171) 171
humans (156) 156
hematology (118) 118
male (104) 104
female (101) 101
middle aged (93) 93
oncology (91) 91
aged (83) 83
adult (78) 78
antineoplastic combined chemotherapy protocols - therapeutic use (78) 78
biological and medical sciences (59) 59
medical sciences (59) 59
prognosis (51) 51
hematologic and hematopoietic diseases (49) 49
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (47) 47
treatment outcome (46) 46
chemotherapy (40) 40
disease-free survival (37) 37
adolescent (34) 34
neoplasm staging (33) 33
retrospective studies (33) 33
rituximab (33) 33
aged, 80 and over (32) 32
lymphoma (32) 32
antineoplastic combined chemotherapy protocols - adverse effects (27) 27
young adult (25) 25
abridged index medicus (24) 24
lymphomas (23) 23
cyclophosphamide - administration & dosage (22) 22
survival analysis (22) 22
antineoplastic combined chemotherapy protocols - administration & dosage (21) 21
hematology, oncology and palliative medicine (21) 21
recurrence (21) 21
tumors (21) 21
cancer (20) 20
combined modality therapy (20) 20
italy (20) 20
risk factors (20) 20
doxorubicin - administration & dosage (19) 19
prednisone - administration & dosage (19) 19
vincristine - administration & dosage (19) 19
antineoplastic agents - therapeutic use (18) 18
hemic and lymphatic diseases (18) 18
lymphoma, large b-cell, diffuse - drug therapy (18) 18
follow-up studies (16) 16
hodgkin disease - drug therapy (16) 16
lymphoma, follicular - pathology (16) 16
lymphoma, non-hodgkin - drug therapy (16) 16
antibodies, monoclonal, murine-derived - administration & dosage (14) 14
lymphoma, follicular - drug therapy (14) 14
stem cells (14) 14
care and treatment (13) 13
patients (13) 13
prospective studies (13) 13
remission induction (13) 13
stem cell transplantation (13) 13
survival rate (13) 13
antineoplastic agents (12) 12
clinical trials (12) 12
transplantation, autologous (12) 12
cyclophosphamide - therapeutic use (11) 11
hematopoietic stem cell transplantation (11) 11
hodgkin's disease (11) 11
lymphoma, large b-cell, diffuse - pathology (11) 11
research (11) 11
time factors (11) 11
bleomycin - administration & dosage (10) 10
cyclophosphamide (10) 10
disease management (10) 10
doxorubicin (10) 10
doxorubicin - therapeutic use (10) 10
follicular lymphoma (10) 10
hodgkin disease - mortality (10) 10
immunotherapy (10) 10
kaplan-meier estimate (10) 10
lymphoma, large b-cell, diffuse - mortality (10) 10
mantle cell lymphoma (10) 10
patient outcomes (10) 10
positron-emission tomography (10) 10
prednisone - therapeutic use (10) 10
transplantation (10) 10
vincristine - therapeutic use (10) 10
analysis (9) 9
antibodies, monoclonal, murine-derived - therapeutic use (9) 9
clinical trials as topic (9) 9
diffuse large b-cell lymphoma (9) 9
drug therapy (9) 9
hodgkin disease - therapy (9) 9
hodgkin lymphoma (9) 9
immune system diseases (9) 9
leukemia (9) 9
lymphoma, non-hodgkin - pathology (9) 9
lymphoma, non-hodgkin - therapy (9) 9
predictive value of tests (9) 9
salvage therapy (9) 9
antibodies, monoclonal - therapeutic use (8) 8
cyclophosphamide - adverse effects (8) 8
doxorubicin - adverse effects (8) 8
drug administration schedule (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


HemaSphere, ISSN 2572-9241, 06/2019, Volume 3, p. 112
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 07/2011, Volume 29, Issue 20, pp. 2766 - 2772
Journal Article
The lancet oncology, ISSN 1470-2045, 09/2018, Volume 19, Issue 9, pp. 1144 - 1146
Journal Article
The lancet oncology, ISSN 1470-2045, 02/2018, Volume 19, Issue 2, pp. 162 - 163
Journal Article
The lancet oncology, ISSN 1470-2045, 2014, Volume 15, Issue 7, pp. 730 - 737
Journal Article
The lancet oncology, ISSN 1470-2045, 10/2017, Volume 18, Issue 10, pp. e558 - e558
Journal Article
Future oncology (London, England), ISSN 1479-6694, 04/2017, Volume 13, Issue 10, pp. 859 - 862
Journal Article
Journal Article
The New England journal of medicine, ISSN 0028-4793, 07/2011, Volume 365, Issue 3, pp. 203 - 212
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | General aspects | Medical sciences | Doxorubicin - therapeutic use | Dacarbazine - adverse effects | Dacarbazine - therapeutic use | Humans | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - therapeutic use | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Young Adult | Hodgkin Disease - radiotherapy | Bleomycin - therapeutic use | Vinblastine - adverse effects | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Adult | Female | Etoposide - adverse effects | Prednisone - adverse effects | Kaplan-Meier Estimate | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Etoposide - therapeutic use | Combined Modality Therapy | Bleomycin - adverse effects | Remission Induction | Disease-Free Survival | Procarbazine - adverse effects | Procarbazine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hodgkin Disease - therapy | Adolescent | Vincristine - therapeutic use | Vincristine - adverse effects | Neoplasm Staging | Doxorubicin - adverse effects | Prednisone - therapeutic use | Procarbazine | Vinblastine | Disease | Etoposide | Prednisone | Family medical history | Radiation therapy | Patients | Lymphoma | Doxorubicin | Survival | Vincristine | Studies | Hepatitis | Dacarbazine | Cyclophosphamide | Chemotherapy | Bleomycin | Tomography | Hodgkin's disease | Index Medicus | Abridged Index Medicus
Journal Article
by Horwitz, Steven and O'Connor, Owen A and Pro, Barbara and Illidge, Tim and Fanale, Michelle and Advani, Ranjana and Bartlett, Nancy L and Christensen, Jacob Haaber and Morschhauser, Franck and Domingo-Domenech, Eva and Rossi, Giuseppe and Kim, Won Seog and Feldman, Tatyana and Lennard, Anne and Belada, David and Illés, Árpád and Tobinai, Kensei and Tsukasaki, Kunihiro and Yeh, Su-Peng and Shustov, Andrei and Hüttmann, Andreas and Savage, Kerry J and Yuen, Sam and Iyer, Swaminathan and Zinzani, Pier Luigi and Hua, Zhaowei and Little, Meredith and Rao, Shangbang and Woolery, Joseph and Manley, Thomas and Trümper, Lorenz and Aboulafia, David and Advani, Ranjana and Alpdogan, Onder and Ando, Kiyoshi and Arcaini, Luca and Baldini, Luca and Bellam, Naresh and Bartlett, Nancy and Belada, David and Yehuda, Dina Ben and Benedetti, Fabio and Borchman, Peter and Bordessoule, Dominique and Brice, Pauline and Briones, Javier and Caballero, Dolores and Carella, Angelo Michele and Chang, Hung and Cheong, June Weon and Cho, Seok-Goo and Choi, Ilseung and Choquet, Sylvain and Colita, Andrei and Congui, Angela Giovanna and D'amore, Francesco and Dang, Nam and Davison, Kelly and de Guibert, Sophie and Brown, Peter de Nully and Delwail, Vincent and Demeter, Judit and di Raimondo, Francesco and Do, Young Rok and Domingo, Eva and Douvas, Michael and Dreyling, Martin and Ernst, Thomas and Fanale, Michelle and Fay, Keith and Feldman, Tatyana and Ferrero, Silvia Fernandez and Flinn, Ian Winchester and Forero-Torres, Andres and Fox, Christopher and Friedberg, Jonathan and Fukuhara, Noriko and Garcia-Marco, Jose and Cruz, Jorge Gayoso and Codina, Jose Gomez and Gressin, Remy and Grigg, Andrew and Gurion, Ronit and Christensen, Jacob Haaber and Haioun, Corinne and Hajek, Roman and Hanel, Mathias and Hatake, Kiyohiko and Hensen, Robert and Horowitz, Netanel and Horwitz, Steven and Huttmann, Andreas and Illes, Arpad and Illidge, Tim and Ishizawa, Kenichi and Islas-Ohlmayer, Miguel and Jacobsen, Eric and Janakiram, Murali and Jurczak, Wojciech and Kaminski, Mark and ... and ECHELON-2 Study Group and ECHELON 2 Study Grp
The Lancet (British edition), ISSN 0140-6736, 01/2019, Volume 393, Issue 10168, pp. 229 - 240
Journal Article
Journal Article